The morning read.

Crypto is repricing sharply upward while U.S.-Iran ceasefire expectations collapse. Bitcoin markets jumped 32 points to 78% on $142K of volume, with Ethereum climbing 29 points to 72% on thinner liquidity. The crypto rally is correlated across four Bitcoin tenor markets and four Ethereum markets — all climbing 29–41 points in 24 hours — but news feeds show no single catalyst. Cointelegraph and CoinDesk report general "rally" language tied to regulatory clarity and Asian chip-stock rebounds, but two of three matched sources contradict the Bitcoin move's direction. Meanwhile, the market on a U.S.-Iran effective ceasefire by July 24 dropped 10.5 points to 9.5% on $119K of volume as BBC and Oil Price report the seventh consecutive night of U.S. strikes on Iran.

The Iran-oil chain shows internal tension. Ceasefire probability is collapsing, yet oil markets are climbing: WTI hitting $85 in July rose 24 points to 82% on $50K volume, with ABC News reporting oil "soaring over 10%" on Middle East tensions. But the Strait of Hormuz normalization market sits at just 1%, effectively pricing permanent disruption, while the closure market dropped 5 points to 5% despite Houthi shipping-target probability rising 17 points to 48%. The money is saying oil supply risk is rising but chokepoint closure remains unlikely — a narrow corridor of disruption without full blockade.

Ukraine command uncertainty eased sharply: the market on General Oleksandr Syrskyi being removed as Commander-in-Chief by July 31 fell 25 points to 63% on $103K of volume. Deutsche Welle and Daily Sabah report Ukraine lawmakers approving a new prime minister and a new acting defense minister, but two of three sources contradict the Syrskyi-removal direction — the personnel changes are happening around him, not to him.

U.S.-Iran effective ceasefire by July 24 at 9.5% — The crowd is pricing near-zero chance of a pause in the next 72 hours. The picture changes if the market climbs above 20% on another $100K+ of volume, signaling diplomatic back-channel progress not yet visible in public reporting.

• Mismatch Between Cancer Burden and Clinical Trial Activity in the European Union: Analysis of Incidence, per Capita Indicators and Commercia — Cancers (Basel)